Evidence map›Paper›PMID 41327202›Full record

ArticleBMC musculoskeletal disorders2025

Surgical outcomes of limb-salvage surgery with or without femoral vein reconstruction for soft tissue sarcomas of the thigh.

Wenquan Xu, Jinxin Hu, Xiaojun Zhu, Tao Zhang

Abstract read
In one paragraph

Article in BMC musculoskeletal disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Wenquan XuDepartment of Musculoskeletal Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, P. R. China.
Jinxin HuDepartment of Musculoskeletal Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, P. R. China.
Xiaojun ZhuDepartment of Musculoskeletal Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, P. R. China. zhuxj@sysucc.org.cn.
Tao ZhangGuangzhou Health Science College, Guangzhou, 510450, Guangdong, P. R. China. zhangtao@gzws.edu.cn.

Funding

Characteristic Innovation Projects for General Higher Education Institutions in Guangdong Province in China No. 2024KTSCX294
6 · The paper itself

Abstract

backgroundLimb salvage surgery for thigh soft tissue sarcomas (STSs) involving the femoral vasculature often necessitates arterial reconstruction. However, whether femoral vein reconstruction is needed remains controversial. PURPOSES: This study aimed to evaluate the outcomes of limb salvage procedures utilizing femoral vessel replacement in patients diagnosed with thigh soft tissue sarcomas involving the femoral vasculature.

methodWe conducted a retrospective review of patients with thigh STSs who underwent limb salvage surgery and vascular reconstruction. Twelve patients were enrolled and divided into two groups on the basis of whether femoral vein was reconstructed. Five received femoral artery and vein reconstruction (group A) and seven were treated with femoral artery reconstruction alone (group B). In our cohort, vascular reconstructions were predominantly performed with prosthetic grafts due to the unavailability of suitable autologous conduits or patient preference, while only two patients received autologous venous grafts. We used the Enneking and Musculoskeletal Tumor Society (MSTS) systems to stage our patients. We assessed complications, MSTS function, local recurrence and survival.

resultsAll patients were Enneking IIB. A wide margin excision was achieved in all patients. The great saphenous vein was preserved in group A (2/5) and group B (3/7). The mean age of the patients for group A and group B was 50.8 and 43.7 years, respectively. The median follow-up period for group A and group B was 50 months (range, 30-77 months) and 43 months (range, 24-62 months), respectively. The mean operation time of Group B was substantially less than that of group A (P<0.05). There was a significant difference in the venous embolism rate between group A(3/5) and group B in the perioperative period. No significant differences were found between the two groups in terms of hematoma formation, delayed wound healing, incision infection rate, reoperation rate, overall disease-free survival, 2-year arterial patency rate and limb salvage rate. No patient had local recurrence and one case in group B developed metastasis. The mean Musculoskeletal Tumor Society score of group A and group B at the final follow-up was 23 points and 25 points, respectively.

conclusionsFemoral arterial reconstruction alone effectively treats thigh STSs involving the femoral vasculature while femoral vein reconstruction does not significantly improve management in these cases. LEVEL OF EVIDENCE: IV.

Indexed as

Femoral VeinLimb SalvagePlastic Surgery ProceduresSarcomaSoft Tissue NeoplasmsThighVascular Surgical ProceduresAdultAgedFemaleFemoral ArteryHumansMaleMiddle AgedRetrospective StudiesTreatment OutcomeComplicationsFemoral vessel replacementLimb-salvage surgeryLower extremitiesSoft tissue sarcoma

Identifiers

PMID41327202
PMCPMC12667068

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.